Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The American Academy of Neurology's Top Five Choosing Wisely recommendations.
MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8(+) T cells.
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial.
Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system.
Chronic cerebrospinal venous insufficiency: masked multimodal imaging assessment.
Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica.
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.
Visual Functional and Histopathological Correlation in Experimental Autoimmune Optic Neuritis.
Opposing Effects of Membrane-Anchored CX3CL1 on Amyloid and Tau Pathologies via the p38 MAPK Pathway.
The cost burden of multiple sclerosis in the United States: a systematic review of the literature.
Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved.
Safety Study of GNbAC1 in Multiple Sclerosis Patients
Mechanism of action, pharmacokinetics, adverse effects, and therapeutic uses of amiloride hydrochloride, a new potassium-sparing diuretic.
Phenytoin (Dilantin) and acupuncture therapy in the treatment of intractable oral and facial pain.
Changes in JC Virus-Specific T Cell Responses during Natalizumab Treatment and in Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.
Neuromyelitis optica.
Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment.
Long term follow up of peripheral lymphocyte subsets in a cohort of multiple sclerosis patients treated with natalizumab.
Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing-remitting multiple sclerosis over 24weeks of therapy with subcutaneous interferon beta-1a three times weekly.
Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: A longitudinal study.
A Herpes Simplex Virus-Derived Replicative Vector Expressing LIF Limits Experimental Demyelinating Disease and Modulates Autoimmunity.
UPDATE 2-FDA panel supports approval of Sanofi's MS drug Lemtrada
Video game training enhances cognitive control in older adults.
Demyelination: the role of reactive oxygen and nitrogen species.
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.

Pages